Egyptian International Pharmaceutical Industries Company (EGX: PHAR)
Egypt
· Delayed Price · Currency is EGP 47.20
+0.10 (0.21%)
At close: Nov 21, 2024
PHAR Ratios and Metrics
Market cap in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 7,021 | 5,430 | 3,621 | 4,155 | 4,309 | 6,592 | Upgrade
|
| Market Cap Growth | 116.44% | 49.96% | -12.86% | -3.57% | -34.63% | -22.13% | Upgrade
|
| Enterprise Value | 14,770 | 9,630 | 5,388 | 5,509 | 5,532 | 6,985 | Upgrade
|
| Last Close Price | 47.20 | 34.75 | 25.21 | 26.64 | 25.71 | 36.40 | Upgrade
|
| PE Ratio | 6.04 | 6.60 | 5.63 | 8.52 | 8.86 | 9.83 | Upgrade
|
| Forward PE | - | 5.92 | 5.77 | 6.23 | 7.52 | 8.17 | Upgrade
|
| PS Ratio | 1.00 | 1.04 | 0.92 | 1.22 | 1.49 | 1.93 | Upgrade
|
| PB Ratio | 1.47 | 1.27 | 1.12 | 1.40 | 1.51 | 2.23 | Upgrade
|
| P/TBV Ratio | 1.53 | 1.28 | 1.12 | 1.40 | 1.52 | 2.23 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 63.88 | Upgrade
|
| P/OCF Ratio | - | 60.09 | - | 10.83 | 26.14 | 23.52 | Upgrade
|
| PEG Ratio | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | Upgrade
|
| EV/Sales Ratio | 2.11 | 1.84 | 1.36 | 1.62 | 1.92 | 2.05 | Upgrade
|
| EV/EBITDA Ratio | 8.19 | 7.33 | 7.10 | 6.35 | 7.61 | 8.24 | Upgrade
|
| EV/EBIT Ratio | 8.67 | 7.95 | 8.14 | 7.09 | 9.42 | 9.97 | Upgrade
|
| EV/FCF Ratio | -4.03 | - | - | - | - | 67.70 | Upgrade
|
| Debt / Equity Ratio | 1.85 | 1.15 | 0.88 | 0.59 | 0.63 | 0.34 | Upgrade
|
| Debt / EBITDA Ratio | 5.13 | 3.74 | 3.76 | 2.03 | 2.47 | 1.20 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 9.86 | Upgrade
|
| Asset Turnover | 0.57 | 0.62 | 0.66 | 0.66 | 0.61 | 0.82 | Upgrade
|
| Inventory Turnover | 1.37 | 1.35 | 1.20 | 1.08 | 1.04 | 1.46 | Upgrade
|
| Quick Ratio | 0.57 | 0.65 | 0.54 | 0.67 | 1.02 | 0.92 | Upgrade
|
| Current Ratio | 1.56 | 1.94 | 1.72 | 2.13 | 2.13 | 2.27 | Upgrade
|
| Return on Equity (ROE) | 26.23% | 21.95% | 20.71% | 16.78% | 16.81% | 23.43% | Upgrade
|
| Return on Assets (ROA) | 8.33% | 9.03% | 6.89% | 9.46% | 7.77% | 10.57% | Upgrade
|
| Return on Capital (ROIC) | 9.00% | 9.90% | 7.63% | 10.35% | 8.53% | 12.02% | Upgrade
|
| Earnings Yield | 16.56% | 15.15% | 17.76% | 11.74% | 11.29% | 10.17% | Upgrade
|
| FCF Yield | -52.17% | -40.52% | -23.75% | -1.28% | -0.90% | 1.57% | Upgrade
|
| Dividend Yield | 2.12% | 2.88% | 3.97% | 5.63% | - | - | Upgrade
|
| Payout Ratio | 37.32% | 37.67% | 61.14% | 78.64% | 103.41% | 74.32% | Upgrade
|
| Buyback Yield / Dilution | -50.00% | - | -1.64% | 1.61% | - | Upgrade
| |
| Total Shareholder Return | 2.12% | -47.12% | 3.97% | 3.99% | 1.61% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.